Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

expert roundtables

$Expert Roundtables Podcast: Salvage Therapy After BCMA-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma$

Expert Roundtables Podcast: Salvage Therapy After BCMA-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

expert roundtables
By Ajai Chari, MD; Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Robert Z. Orlowski, MD, PhD

Later-line Treatment With Antibody-Drug Conjugates for HR+/HER2- Metastatic Breast Cancer

Later-line Treatment With Antibody-Drug Conjugates for HR+/HER2- Metastatic Breast Cancer

expert roundtables
By Joanne Mortimer, MD, FACP, FASCO; David Rimm, MD, PhD; Sagar D. Sardesai, MBBS

Novel Therapeutic Strategies in Multiple Myeloma

Novel Therapeutic Strategies in Multiple Myeloma

expert roundtables
By Rafat Abonour, MD; Rafael Fonseca, MD; Noopur Raje, MD

Expert Roundtables Podcast: Treating Patients With HR+/HER2- Metastatic Breast Cancer at Initial Diagnosis

Expert Roundtables Podcast: Treating Patients With HR+/HER2- Metastatic Breast Cancer at Initial Diagnosis

expert roundtables
By Joanne Mortimer, MD, FACP, FASCO; David Rimm, MD, PhD; Sagar D. Sardesai, MBBS

Expert Roundtables Podcast: The Role of Chimeric Antigen Receptor T-Cell Immunotherapy in Multiple Myeloma

Expert Roundtables Podcast: The Role of Chimeric Antigen Receptor T-Cell Immunotherapy in Multiple Myeloma

expert roundtables
By Rafat Abonour, MD; Rafael Fonseca, MD; Noopur Raje, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?